FDA Approves Once-Monthly Injection for Opioid Addiction

Share this content:
FDA Approves Once-Monthly Injection for Opioid Addiction
FDA Approves Once-Monthly Injection for Opioid Addiction

FRIDAY, Dec. 1, 2017 (HealthDay News) -- Sublocade, a once-monthly injection of buprenorphine to treat opioid use disorder, has been approved by the U.S. Food and Drug Administration.

Buprenorphine has been shown to reduce opioid withdrawal symptoms and the desire to use opioids, "without causing the cycle of highs and lows associated with opioid misuse or abuse," the FDA said.

Sublocade was evaluated in clinical studies involving 848 adults who were diagnosed with moderate-to-severe cases of opioid use disorder. The most common side effects included constipation, nausea, vomiting, headache, drowsiness, and injection-site pain. Sublocade's safety and effectiveness were not evaluated in individuals under age 17, the FDA said.

The maker of Sublocade -- Indivior -- is required to conduct additional studies to see if some patients could benefit from a dose of Sublocade that's higher than currently approved.

Indivior is based in the United Kingdom.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

FDA Approves First Generic Under-the-Tongue Suboxone

FDA Approves First Generic Under-the-Tongue Suboxone

May only be prescribed by Drug Addiction Treatment Act-certified prescribers

Kellogg's Honey Smacks Cereal Recalled Due to Salmonella Risk

Kellogg's Honey Smacks Cereal Recalled Due to <i>Salmonella</i> ...

Twenty-four people have been hospitalized, but no deaths have been reported

Portable Music Player Use Linked to Hearing Loss in Children

Portable Music Player Use Linked to Hearing Loss ...

Increased odds of high-frequency hearing loss with portable music player use

is free, fast, and customized just for you!




Already a member?

Sign In Now »